Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

Three UCLA researchers receive multimillion-dollar grant from state's stem cell agency

Three researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have received awards totaling more than $18 million from the California Institute for Regenerative Medicine, the state's stem cell agency.

31 Oct 2019

NCCN publishes new clinical practice guidelines for hematopoietic cell transplantation

Today, the National Comprehensive Cancer Network published new NCCN Clinical Practice Guidelines in Oncology for Hematopoietic Cell Transplantation, also known as stem cell transplant or historically as bone marrow transplant.

30 Oct 2019

Cancer drug may delay progression of bone and other myeloma-related organ damage

The largest randomized trial in asymptomatic patients with smoldering multiple myeloma suggests that lenalidomide, a cancer drug, may delay the onset of bone and other myeloma-related organ damage.

28 Oct 2019

New screening test detects 20 types of cancer

Researchers from the Dana-Farber Cancer Institute have developed a new blood test that would accurately determine the presence of several types of cancers. The results of their multi-centre clinical trial to prove the effectiveness of their test was presented by the researchers at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain, on the 28th of September 2019.

30 Sep 2019

New blood test shows ability to accurately detect numerous types of cancer

A new blood test in development has shown ability to screen for numerous types of cancer with a high degree of accuracy, a trial of the test shows.

28 Sep 2019

New method harnesses the power of killer T cells to attack tumor cells, treat cancer

They've been called the "special forces" of the immune system: invariant natural killer T cells. Although there are relatively few of them in the body, they are more powerful than many other immune cells.

24 Sep 2019

Mitochondrial fission factor could represent a promising target for cancer therapy

Researchers at The Wistar Institute have described the role of mitochondrial fission factor (MFF) in controlling survival of cancer cells, suggesting the protein could represent a promising therapeutic target. They also found that expression of MFF is regulated by Myc, a ubiquitous mediator of cell proliferation that contributes to development of many cancer types.

20 Sep 2019

Exposure to 9/11 WTC dust associated with increased risk of heart disease in NYC firefighters

A new study of New York City firefighters has found that exposure to 9/11 World Trade Center dust is associated with a significantly increased long-term risk of cardiovascular disease.

7 Sep 2019

Younger people getting cancer due to obesity

Obesity rates around the globe are ballooning - literally! Approximately 1.9 billion adults who are 18 years and older were overweight in 2016, and of these, more than 650 million were obese. The number of obese people has nearly tripled since 1975.

4 Sep 2019

New therapy found to be effective for patients with a particular type of bone marrow cancer

Mount Sinai researchers have found a new type of therapy to be effective for patients with a particular type of bone marrow cancer that is resistant to several standard therapies, according to results of a clinical trial published in The New England Journal of Medicine in August.

22 Aug 2019

Cancer survivors could be at greater risk of cardiovascular diseases

Over the last few decades, medical progress has led to the survival of many more people with cancer. However, a new study published in The Lancet shows that this cohort has a higher risk of cardiovascular disease (CVD) than controls without cancer, due to a number of reasons.

21 Aug 2019

Roswell Park receives more than $15 million in grants for cancer research

Roswell Park Comprehensive Cancer Center researchers have received more than a dozen recent grant awards totaling more than $15.4 million.

14 Aug 2019

UAMS Myeloma Center receives $542,486 grant from Leukemia & Lymphoma Society

Brian Walker, Ph.D., with the Myeloma Center at the University of Arkansas for Medical Sciences has received a $542,486, three-year grant from the Leukemia & Lymphoma Society to look at changes in the DNA sequence that effects the development and advancement of multiple myeloma, a cancer of plasma cells in the blood.

12 Aug 2019

Study finds new way to help cancer doctors predict blood clots in patients with multiple myeloma

New research from the Hutchinson Institute for Cancer Outcomes Research- which is based at Fred Hutchinson Cancer Research Center- along with the University of Washington and the Seattle Cancer Care Alliance, identifies a simple way to help cancer doctors caring for patients with multiple myeloma to predict blood clots in order to take preventive action.

19 Jul 2019

Rutgers researchers create new device to see if targeted cancer therapy is working

Rutgers researchers have created a device that can determine whether targeted chemotherapy drugs are working on individual cancer patients.

17 Jul 2019

AI-enabled device detects if targeted chemotherapy is working

A new portable device that utilizes artificial intelligence (AI) and biosensors can rapidly detect if cancer cells thrive after chemotherapy treatment.

17 Jul 2019

Engineered stem cells offer new treatment for metastatic bone cancer

Engineered stem cells could help treat metastatic cancers in bone without killing normal surrounding bone.

9 Jul 2019

$FDA grants accelerated approval to new treatment for refractory multiple myeloma$

FDA grants accelerated approval to new treatment for refractory multiple myeloma

Today, the U.S. Food and Drug Administration granted accelerated approval to Xpovio (selinexor) tablets in combination with the corticosteroid dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma who have received at least four prior therapies and whose disease is resistant to several other forms of treatment, including at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody.

3 Jul 2019

Have cancer, must travel: Patients left in lurch after hospital closes

One Monday in February, 65-year-old Karen Endicott-Coyan gripped the wheel of her black 2014 Ford Taurus with both hands as she made the hour-long drive from her farm near Fort Scott to Chanute.

1 Jul 2019

Study identifies risk factors for cardiotoxicity with relapsed multiple myeloma therapy

More than half of patients with relapsed multiple myeloma treated with carfilzomib experienced cardiac issues during treatment, according to a multi-institutional study published June 12 in Journal of Clinical Oncology.

14 Jun 2019

Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

Three UCLA researchers receive multimillion-dollar grant from state's stem cell agency

NCCN publishes new clinical practice guidelines for hematopoietic cell transplantation

Cancer drug may delay progression of bone and other myeloma-related organ damage

New screening test detects 20 types of cancer

New blood test shows ability to accurately detect numerous types of cancer

New method harnesses the power of killer T cells to attack tumor cells, treat cancer

Mitochondrial fission factor could represent a promising target for cancer therapy

Exposure to 9/11 WTC dust associated with increased risk of heart disease in NYC firefighters

Younger people getting cancer due to obesity

New therapy found to be effective for patients with a particular type of bone marrow cancer

Cancer survivors could be at greater risk of cardiovascular diseases

Roswell Park receives more than $15 million in grants for cancer research

UAMS Myeloma Center receives $542,486 grant from Leukemia & Lymphoma Society

Study finds new way to help cancer doctors predict blood clots in patients with multiple myeloma

Rutgers researchers create new device to see if targeted cancer therapy is working

AI-enabled device detects if targeted chemotherapy is working

Engineered stem cells offer new treatment for metastatic bone cancer

FDA grants accelerated approval to new treatment for refractory multiple myeloma

Have cancer, must travel: Patients left in lurch after hospital closes

Study identifies risk factors for cardiotoxicity with relapsed multiple myeloma therapy

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in